<SEC-DOCUMENT>0000883984-19-000024.txt : 20190708
<SEC-HEADER>0000883984-19-000024.hdr.sgml : 20190708
<ACCEPTANCE-DATETIME>20190708170356
ACCESSION NUMBER:		0000883984-19-000024
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190708
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190708
DATE AS OF CHANGE:		20190708

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICU MEDICAL INC/DE
		CENTRAL INDEX KEY:			0000883984
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330022692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34634
		FILM NUMBER:		19945825

	BUSINESS ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
		BUSINESS PHONE:		949-366-2183

	MAIL ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-k7819items502and901.htm
<DESCRIPTION>8-K 7.8.19 ITEMS 5.02 AND 9.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="scd3b6931a3d3443dacaf07120bda06a9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#160;FORM&#160;8-K</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;July 8, 2019</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">ICU MEDICAL, INC.</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:637px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:198px;"></td><td style="width:18px;"></td><td style="width:200px;"></td><td style="width:18px;"></td><td style="width:200px;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DELAWARE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-34634</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">33-0022692</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction</font></div><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of incorporation) </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer</font></div><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.) </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:96px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:427px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:298px;"></td><td style="width:46px;"></td><td style="width:81px;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">951 Calle Amanecer, San Clemente, California</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">92673</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(949) 366-2183</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant's telephone number, including area code</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former name or former address, if changed since last report)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:5px;"></td><td style="width:21px;"></td><td style="width:657px;"></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Securities registered pursuant to Section 12(b) of the Act:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:36%;"></td><td style="width:21%;"></td><td style="width:43%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Title of each class</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Trading Symbol</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name of each exchange on which registered</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock, par value $0.10 per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ICUI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Nasdaq Stock Market LLC</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Global Select Market)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:684px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:5px;"></td><td style="width:225px;"></td><td style="width:226px;"></td><td style="width:226px;"></td></tr><tr><td colspan="4" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s0be8ff9608794b9abeb494d79fc2f0bf"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 5.02&#160;&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 8, 2019, ICU Medical, Inc. (the &#8220;Company&#8221;) announced that Scott E. Lamb, Chief Financial Officer and Treasurer of the Company, informed the Company of his intention to retire as CFO from the Company effective after the filing of the Company&#8217;s annual report on Form 10-K for the year ended 2019. After retirement as Chief Financial Officer, Scott will serve in an advisory role to ensure a smooth transition of responsibilities. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01. Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d) Exhibits</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;99.1 </font><a style="font-family:inherit;font-size:10pt;" href="exhibit991.htm"><font style="font-family:inherit;font-size:10pt;">Press release, dated July 8, 2019 announcing Mr. Lamb&#8217;s intention to retire as CFO</font></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="se84fb89d843a41d996584a08052f4483"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:617px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:292px;"></td><td style="width:32px;"></td><td style="width:293px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ICU Medical, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: July 8, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">/s/ VIVEK JAIN</font></div><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vivek Jain</font></div><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s87a4cbd67c0a4931b696fe7fba08a71c"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:10px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;"><img src="icumedicala03.jpg" alt="icumedicala03.jpg" style="height:81px;width:258px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ICU Medical CFO Announces Intention to Retire from CFO Role After Close of FY19</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SAN CLEMENTE, Calif., July 8, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Scott E. Lamb, its Chief Financial Officer and Treasurer, has informed the Company of his intention to retire from the Company effective after filing the FY2019 10-K, following over 16 years of service with the Company. After retirement as CFO, Mr. Lamb will serve in an advisory role to ensure a smooth transition of responsibilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;Scott has been an integral part of ICU&#8217;s leadership team for many years,&#8221; said Chief Executive Officer Vivek Jain. &#8220;On behalf of the Board and our entire Company, I would like to thank Scott for his dedication and many significant contributions. Scott joined the company when it was approximately $100 million in revenues and was a key contributor during our changes over the last five years.&#8221; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following the change, current Corporate Vice President, Brian Bonnell will be promoted to Chief Financial Officer and Treasurer. Brian Bonnell joined ICU Medical in 2018 and is currently responsible for the Treasury and Tax functions. Prior to joining ICU, Mr. Bonnell was Treasurer and Head of FP&amp;A for Alere Inc. from 2015 until its acquisition by Abbott. Prior to Alere, Mr. Bonnell spent seven years at CareFusion Corporation, as both SVP of Tax and Treasury and as VP of Finance for Medical Systems, the $2.4 billion revenue segment that included infusion pumps and automated dispensing equipment. Prior to its spin-off of CareFusion, Mr. Bonnell spent seven years in a variety of Finance roles for Cardinal Health. Mr. Bonnell started his career in 1995 and spent seven years in the audit practice of Arthur Andersen LLP. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;"><hr></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">About ICU Medical, Inc.</font><font style="font-family:inherit;font-size:10pt;">: ICU Medical, Inc. (Nasdaq: ICUI) develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical safety and workflow goals. ICU Medical is headquartered in San Clemente, California. For more information, visit the Company's website at www.icumed.com.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Forward Looking Statements: </font><font style="font-family:inherit;font-size:10pt;">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as ''will,'' ''expect,'' ''believe,'' ''could,'' ''would,'' ''estimate,'' ''continue,'' ''build,'' ''expand'' or the negative thereof or comparable terminology, and may include (without limitation) information regarding the Company's expectations, goals or intentions regarding the future. These forward-looking statements are based on Management's current expectations, estimates, forecasts and projections about the Company and assumptions Management believes are reasonable, all of which are subject to risks and uncertainties that could cause actual results and events to differ materially from those stated in the forward-looking statements. Future results are subject to risks and uncertainties, including the risk factors, and other risks and uncertainties, described in the Company's filings with the Securities and Exchange Commission, which include those in the Annual Report on Form 10-K for the year ended December 31, 2018. Forward-looking statements contained in this press release are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">INVESTOR CONTACT: </font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Scott Lamb, Chief Financial Officer</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">ICU Medical, Inc.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(949) 366-2183</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">MEDIA CONTACT:</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tom McCall, Corporate Vice President</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">ICU Medical, Inc.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(949) 366-4368</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>icumedicala03.jpg
<TEXT>
begin 644 icumedicala03.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ] ,(# 2(  A$! Q$!_\0
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M.$;=E?\ 5'0_M9?'OQ1\0/BEJOA32=0NK;0;"[.G0Z?8NR&[F5MK,^WECOR
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M5V]5;:W;N<DWQ(U[XJ>%OAIHNFW<FAZGXLMY;K5[ZS.);2WMU N!%_=9Y65
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:@X22U=_3T-:6#A1FIQ;T5O4?1117(>@?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
